September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
September 02, 2022
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 02, 2022
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including car ...
September 02, 2022Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
September 02, 2022
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...
September 02, 2022
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...
September 02, 2022
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 01, 2022
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 01, 2022
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
September 01, 2022
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...
August 30, 2022
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...
August 29, 2022
August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...
August 26, 2022
August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...
August 25, 2022
August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling Heart ...
August 25, 2022
August 24, 2022 — Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to ...
August 24, 2022